|
Name |
Dimethyl icosanedioate
|
Molecular Formula | C22H42O4 | |
IUPAC Name* |
dimethyl icosanedioate
|
|
SMILES |
COC(=O)CCCCCCCCCCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C22H42O4/c1-25-21(23)19-17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-18-20-22(24)26-2/h3-20H2,1-2H3
|
|
InChIKey |
PODMJVMUYCFFMK-UHFFFAOYSA-N
|
|
Synonyms |
Dimethyl icosanedioate; 42235-38-1; Eicosanedioic Acid Dimethyl Ester; Icosanedioic Acid Dimethyl Ester; Dimethyl Eicosanedioate; Dimethyl icosanedioate #; SCHEMBL495288; Dimethyl eicosanedioate; >95%; DTXSID10340707; Eicosanebioic acid, dimethyl ester; MFCD00059302; ZINC15149612; BS-23540; CS-0197223; E0330; FT-0756671; D90485; A924032
|
|
CAS | 42235-38-1 | |
PubChem CID | 566668 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 370.6 | ALogp: | 8.4 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 21 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 52.6 | Aromatic Rings: | 0 |
Heavy Atoms: | 26 | QED Weighted: | 0.197 |
Caco-2 Permeability: | -4.916 | MDCK Permeability: | 0.00001490 |
Pgp-inhibitor: | 0.127 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.998 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0.234 | Plasma Protein Binding (PPB): | 96.12% |
Volume Distribution (VD): | 1.035 | Fu: | 1.32% |
CYP1A2-inhibitor: | 0.291 | CYP1A2-substrate: | 0.19 |
CYP2C19-inhibitor: | 0.356 | CYP2C19-substrate: | 0.066 |
CYP2C9-inhibitor: | 0.209 | CYP2C9-substrate: | 0.946 |
CYP2D6-inhibitor: | 0.113 | CYP2D6-substrate: | 0.047 |
CYP3A4-inhibitor: | 0.554 | CYP3A4-substrate: | 0.057 |
Clearance (CL): | 5.247 | Half-life (T1/2): | 0.368 |
hERG Blockers: | 0.241 | Human Hepatotoxicity (H-HT): | 0.043 |
Drug-inuced Liver Injury (DILI): | 0.51 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.01 | Maximum Recommended Daily Dose: | 0.031 |
Skin Sensitization: | 0.967 | Carcinogencity: | 0.06 |
Eye Corrosion: | 0.919 | Eye Irritation: | 0.726 |
Respiratory Toxicity: | 0.864 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000474 | 0.795 | D00AOJ | 0.533 | ||||
ENC000497 | 0.756 | D07ILQ | 0.489 | ||||
ENC000464 | 0.738 | D00FGR | 0.447 | ||||
ENC000280 | 0.718 | D00MLW | 0.423 | ||||
ENC000724 | 0.689 | D00STJ | 0.414 | ||||
ENC000496 | 0.679 | D0Z5SM | 0.407 | ||||
ENC001181 | 0.675 | D0O1PH | 0.373 | ||||
ENC000357 | 0.651 | D05ATI | 0.344 | ||||
ENC000553 | 0.646 | D0Z1QC | 0.341 | ||||
ENC000271 | 0.641 | D0T9TJ | 0.323 |